Johns Hopkins investigators are testing a way to use drugs that target a cholesterol pathway to enhance the cancer-killing potential of standard chemotherapy drugs. Their tests, in mouse models of pancreatic cancer, may yield ...
Apr 3, 2012
Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma and primary effusion lymphoma (PEL). PELs are aggressive lymphomas with reported median survival time shorter than six ...
Apr 3, 2012
A combination of nab-paclitaxel and carboplatin for the treatment of non-small cell lung cancer may be a promising option for patients ineligible for treatment with bevacizumab, according to data presented at the AACR Annual ...
Apr 3, 2012
Scientists at Fox Chase Cancer Center in Philadelphia have come one step closer to developing the first treatment to target a key pathway in lymphoma. The new findings will be announced at the AACR Annual Meeting 2012 on ...
Apr 3, 2012
(Medical Xpress) -- A new pilot study led by researchers at the Virginia Commonwealth University Pauley Heart Center and the VCU School of Pharmacy shows that targeting and blocking a key molecular player involved with inflammation ...
Apr 3, 2012
Three years ago, Donald Sefcik, senior associate dean of Michigan State University's College of Osteopathic Medicine, set out to write a guide to help medical and physician assistant students study for standardized tests.
Apr 3, 2012
(Medical Xpress) -- A new technique for improving delivery of stem cells may lead to better and faster tissue repair, a breakthrough with promise for sports medicine and military populations.
Apr 3, 2012
